|Bid||54.47 x 1300|
|Ask||54.48 x 2100|
|Day's Range||54.35 - 54.69|
|52 Week Range||44.68 - 55.28|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.11%|
In 1H17, Novartis's (NVS) Gleevec reported revenues of around $1.1 billion, which reflected a ~39% decline on a year-over-year (or YoY) basis.
Vanguard Total International Stock ETF provides investors with a heavily diversified portfolio at a rock-bottom fee.
GlaxoSmithKline (GSK) added new products and improved the supply chain for consumer healthcare products in the last few years.